Zapata Quantum (ZPTA) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
5 Jun, 2026Company overview and business model
Operates as a hardware-agnostic quantum software company, focusing on quantum and hybrid quantum-classical computing applications for enterprise and government clients.
Offers a subscription-based model for its Orquestra platform and related tools, with additional revenue from technical services and government contracts.
Holds over 60 patents and has participated in all technical areas of DARPA's Quantum Benchmarking program.
Underwent a strategic realignment in 2024–2025, refocusing on quantum software after a temporary operational suspension due to liquidity constraints.
Business model relies on direct enterprise sales, channel partnerships, and ecosystem collaborations.
Financial performance and metrics
No revenue generated in 2025 or Q1 2026 due to operational cessation; $3.9M revenue in 2024.
Net income of $9.3M in 2025, compared to a net loss of $38.1M in 2024, driven by gains on extinguishment of liabilities and debt restructuring.
Operating loss of $3.4M in 2025, down from $23.0M in 2024.
Cash balance of $642K as of March 31, 2026; $13.2M as of June 1, 2026, expected to fund operations for at least 12 months.
Stockholders' deficit of $9.4M as of March 31, 2026.
Use of proceeds and capital allocation
Will not receive proceeds from the sale of shares by selling stockholders; proceeds from warrant exercises, if any, will be used for general corporate and working capital purposes.
Recent capital raises include $15M from Series D preferred stock and warrants in April 2026, and $3M from convertible notes and warrants in June 2025.
Latest events from Zapata Quantum
- Q1 2026 net loss rose to $1.3M; $15M Series D financing secured in April extends liquidity.ZPTA
Q1 202615 May 2026 - No 2025 revenue, positive net income from restructuring, but significant going concern risk remains.ZPTA
Q4 202531 Mar 2026 - Revenue up 40% to $2M, gross margin 36%, but net loss widens; $30M+ pipeline drives outlook.ZPTA
Q2 20242 Feb 2026 - Equity line resale of up to 13M shares exposes company to high dilution and ongoing losses.ZPTA
Registration Filing29 Nov 2025